Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-11-06
2007-11-06
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S314000, C514S332000, C514S336000, C514S357000, C546S171000, C546S176000, C546S255000, C546S268100, C546S329000
Reexamination Certificate
active
10823494
ABSTRACT:
The present invention relates to compounds that bind to chemokine receptors, and having the formulawherein each A, X, Y, R1, R2and R3are substituents. The present invention also relates to methods of using such compounds, such as in treating HIV infection and inflammatory conditions such as rheumatoid arthritis. Furthermore, the present invention relates to methods to elevate progenitor and stem cell counts, as well as methods to elevate white blood cell counts, using such compounds.
REFERENCES:
patent: 5021409 (1991-06-01), Murrer et al.
patent: 5583131 (1996-12-01), Bridger et al.
patent: 5698546 (1997-12-01), Bridger et al.
patent: 5817807 (1998-10-01), Bridger et al.
patent: 6001826 (1999-12-01), Murrer et al.
patent: 6365583 (2002-04-01), MacFarland et al.
patent: 2003/0028022 (2003-02-01), Bridger et al.
patent: WO-97/09976 (1997-03-01), None
patent: WO 00/56729 (2000-09-01), None
patent: WO 00/02870 (2000-12-01), None
patent: WO 02/22599 (2002-03-01), None
patent: WO 02/22600 (2002-03-01), None
patent: WO 02/34745 (2002-05-01), None
Brinksma et al, Inorganica Chimica Acta, vol. 337, pp. 75-82, 2002.
Abi-Younes, et al., Circ. Res. (2000) 86:131-138.
Alkhatib, et al., Science (1996) 272:1955-1958.
Arai, et al., Eur. J. Haematol. (2000) 64:323-332.
Arenberg, et al., J. Leukocyte Biol. (1997) 62:554-562.
Aiuti, et al., J. Exp. Med. (1997) 185:111-120.
Blaak, et al., Proc. Natl. Acad. Sci. (2000) 97:1269-1274.
Blanco, et al., Antimicrobial Agents and Chemother. (2000) 44:51-56.
Bleul, et al., J. Exp. Med. (1998) 187:753-762.
Bleul, et al., Nature (1996) 382:829-833.
Bradstock, et al., Leukemia (2000) 14:882-888.
Bridger, et al., J. Med. Chem. (1999) 42:3971-3981.
Burger, et al., Blood (1999) 94:3658-3667.
Carroll, et al., Science (1997) 276:273-276.
Cocchi, et al., Science (1995) 270:1811-1815.
Connor, J. Virol. (1994) 68:4400-4408.
Deng. et al., Nature (1996) 381:661-666.
Donzella, et al., Nature Medicine (1998) 4:72-77.
Dragic, et al., Nature (1996) 381:667-673.
Egberink, et al., J. Virol. (1999) 73:6346-6352.
Eitner, et al., Transplantation (1998) 66:1551-1557.
Fedyk, et al., J. Leukocyte Biol. (1999) 66:667-673.
Feng, et al., Science (1996) 272:872-877.
Gonzalo, et al., J. Immunol. (2000) 165:499-50.
Gupta, et al., J. Biolog. Chem. (1998) 273(7):4282-4287.
Ishii, et al., J. Immunol. (1999) 163:3612-3620.
Lataillade, et al., Blood (2000) 95:756-768.
Liu, et al., Cell (1996) 86:367-377.
Ma, et al., Immunity (1999) 10:463-471.
Maekawa, et al., Internal Medicine (2000) 39:90-100.
Michael, et al., Nature Med. (1997) 3:338-340.
Michael, et al., J. Virol. (1998) 72:6040-6047.
Miedema, et al., Immune. Rev. (1994) 140:35-72.
Moore, et al., J. Invest. Med. (1998) 46:113-120.
Moore, et al., Trends Cardiovasc. Med. (1998) 8:51-58.
Murdoch, et al., (2000) Blood 95:3032-3043.
Nagasawa, et al., Nature (1996) 382:635-638.
Nagase, J. Immunol. (2000) 164:5935-5943.
Nanki, et al., J. Immunol. (2000) 164:5010-5014.
Oberlin, et al., Nature (1996) 382:833-835.
O'Brien, et al., Lancet (1997) 349:1219.
Peled, et al., Science (1999) 283:845-848.
Peled, et al., Blood (2000) 95:3289-3296.
Ponath, Exp. Opin. Invest. Drugs (1998) 7:1-18.
Rana, et al., J. Virol. (1997) 71:3219-3227.
Salcedo, et al., Am. J. Pathol. (1999) 154:1125-1135.
Samson, et al., Nature (1996) 382:722-725.
Schols, et al., J. Exp. Med. (1997) 186:1383-1388.
Schols, et al., Antiviral Research (1997) 35:147-156.
Schuitemaker, et al., J. Virol. (1992) 66:1354-1360.
Seghal, et al., J. Surg. Oncol. (1998) 69:99-104.
Simmons, et al. J. Virol. (1996) 70:8355-8360.
Simmons, et al., J. Virol. (1988) 72:8453-8457.
Tachibana, et al., Nature (1998) 393:591-594.
Tersmette, et al., J. Virol. (1988) 62:2026-2032.
Theodorou, et al., Lancet (1997) 349:1219-1220.
Viardot, et al., Ann. Hematol. (1998) 77:193-197.
Wyatt, et al., Science (1998) 280:1884-1888.
Xia, et al., J. Neurovirology (1999) 5:32-41.
Yssel, et al., Clinical and Experimental Allergy (1998) 28:104-109.
Zhang, et al., AIDS Res. Hum. Retroviruses (1997) 13:1357-1366.
Zhang, et al., J. Virol. (1998) 72:9307-9312.
Zhang, et al., J. Virol. (1999) 73:3443-3448.
International Search Report for PCT/US04/11328, mailed on Oct. 20, 2004, 2 pages.
Baird Ian
Bridger Gary J.
Chen Gang
Harwig Curtis
Kaller Al
Davis Zinna N.
Genzyme Corporation
Morrison & Foerster / LLP
LandOfFree
CXCR4 chemokine receptor binding compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CXCR4 chemokine receptor binding compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CXCR4 chemokine receptor binding compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3859863